Emery Lyndsey A, Tripathi Anusri, King Chialin, Kavanah Maureen, Mendez Jane, Stone Michael D, de las Morenas Antonio, Sebastiani Paola, Rosenberg Carol L
Boston University Medical Center, 650 Albany Street, Boston, MA 02118, USA.
Am J Pathol. 2009 Sep;175(3):1292-302. doi: 10.2353/ajpath.2009.090115. Epub 2009 Aug 21.
Proliferative breast lesions, such as simple ductal hyperplasia (SH) and atypical ductal hyperplasia (ADH), are candidate precursors to ductal carcinoma in situ (DCIS) and invasive cancer. To better understand the relationship of breast lesions to more advanced disease, we used microdissection and DNA microarrays to profile the gene expression of patient-matched histologically normal (HN), ADH, and DCIS from 12 patients with estrogen receptor positive sporadic breast cancer. SH were profiled from a subset of cases. We found 837 differentially expressed genes between DCIS-HN and 447 between ADH-HN, with >90% of the ADH-HN genes also present among the DCIS-HN genes. Only 61 genes were identified between ADH-DCIS. Expression differences were reproduced in an independent cohort of patient-matched lesions by quantitative real-time PCR. Many breast cancer-related genes and pathways were dysregulated in ADH and maintained in DCIS. Particularly, cell adhesion and extracellular matrix interactions were overrepresented. Focal adhesion was the top pathway in each gene set. We conclude that ADH and DCIS share highly similar gene expression and are distinct from HN. In contrast, SH appear more similar to HN. These data provide genetic evidence that ADH (but not SH) are often precursors to cancer and suggest cancer-related genetic changes, particularly adhesion and extracellular matrix pathways, are dysregulated before invasion and even before malignancy is apparent. These findings could lead to novel risk stratification, prevention, and treatment approaches.
增殖性乳腺病变,如单纯性导管增生(SH)和非典型导管增生(ADH),是导管原位癌(DCIS)和浸润性癌的候选前体。为了更好地理解乳腺病变与更晚期疾病的关系,我们使用显微切割和DNA微阵列技术,对12例雌激素受体阳性散发性乳腺癌患者的组织学正常(HN)、ADH和DCIS进行了基因表达谱分析。SH是从部分病例中进行分析的。我们发现DCIS与HN之间有837个差异表达基因,ADH与HN之间有447个,且ADH与HN之间超过90%的基因也存在于DCIS与HN之间的基因中。ADH与DCIS之间仅鉴定出61个基因。通过定量实时PCR在一组独立的患者匹配病变中重现了表达差异。许多与乳腺癌相关的基因和通路在ADH中失调,并在DCIS中持续存在。特别是,细胞黏附和细胞外基质相互作用过度表达。粘着斑是每个基因集中的首要通路。我们得出结论,ADH和DCIS具有高度相似的基因表达,且与HN不同。相比之下,SH似乎与HN更相似。这些数据提供了遗传学证据,表明ADH(而非SH)通常是癌症的前体,并提示与癌症相关的基因变化,特别是黏附和细胞外基质通路,在侵袭前甚至在恶性肿瘤明显之前就已失调。这些发现可能会带来新的风险分层、预防和治疗方法。